rs202169392
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_031418.4(ANO3):c.1290-5_1290-4del variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0364 in 1,548,830 control chromosomes in the GnomAD database, including 2,171 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 106 hom., cov: 26)
Exomes 𝑓: 0.037 ( 2065 hom. )
Consequence
ANO3
NM_031418.4 splice_region, splice_polypyrimidine_tract, intron
NM_031418.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.576
Genes affected
ANO3 (HGNC:14004): (anoctamin 3) The protein encoded by this gene belongs to the TMEM16 family of predicted membrane proteins, that are also known as anoctamins. While little is known about the function of this gene, mutations in this gene have been associated with some cases of autosomal dominant craniocervical dystonia. Cells from individuals with a mutation in this gene exhibited abnormalities in endoplasmic reticulum-dependent calcium signaling. Studies in rat show that the rat ortholog of this protein interacts with, and modulates the activity of a sodium-activated potassium channel. Deletion of this gene caused increased pain sensitivity in the rat model system. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-26553241-TTC-T is Benign according to our data. Variant chr11-26553241-TTC-T is described in ClinVar as [Likely_benign]. Clinvar id is 412867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-26553241-TTC-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.027 (4091/151510) while in subpopulation NFE AF= 0.0442 (2993/67768). AF 95% confidence interval is 0.0428. There are 106 homozygotes in gnomad4. There are 1850 alleles in male gnomad4 subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4091 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANO3 | NM_031418.4 | c.1290-5_1290-4del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000256737.8 | NP_113606.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANO3 | ENST00000256737.8 | c.1290-5_1290-4del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_031418.4 | ENSP00000256737 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0270 AC: 4089AN: 151394Hom.: 106 Cov.: 26
GnomAD3 genomes
AF:
AC:
4089
AN:
151394
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0302 AC: 7210AN: 238746Hom.: 275 AF XY: 0.0304 AC XY: 3921AN XY: 129138
GnomAD3 exomes
AF:
AC:
7210
AN:
238746
Hom.:
AF XY:
AC XY:
3921
AN XY:
129138
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0375 AC: 52339AN: 1397320Hom.: 2065 AF XY: 0.0365 AC XY: 25484AN XY: 697920
GnomAD4 exome
AF:
AC:
52339
AN:
1397320
Hom.:
AF XY:
AC XY:
25484
AN XY:
697920
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0270 AC: 4091AN: 151510Hom.: 106 Cov.: 26 AF XY: 0.0250 AC XY: 1850AN XY: 74022
GnomAD4 genome
AF:
AC:
4091
AN:
151510
Hom.:
Cov.:
26
AF XY:
AC XY:
1850
AN XY:
74022
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
30
AN:
3474
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
ANO3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 27, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Dystonia 24 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 03, 2021 | - - |
Dystonic disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at